Does bevacizumab improve survival in patients with metastatic colorectal cancer treated with chemotherapy?

Axel Grothey

doi:10.1038/ncponc0380

Does bevacizumab improve survival in patients with metastatic colorectal cancer treated with chemotherapy?

Axel Grothey

Medical Oncology

Research output: Contribution to journal › Short survey › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	22-23
Number of pages	2
Journal	Nature Clinical Practice Oncology
Volume	3
Issue number	1
DOIs	https://doi.org/10.1038/ncponc0380
State	Published - Jan 2006

Keywords

Bevacizumab
Colorectal cancer
Fluorouracil
Leucovorin
Survival

ASJC Scopus subject areas

Oncology

Access to Document

10.1038/ncponc0380

Cite this

@article{998037c885454aa4bf9b2e92423c5aaf,

title = "Does bevacizumab improve survival in patients with metastatic colorectal cancer treated with chemotherapy?",

keywords = "Bevacizumab, Colorectal cancer, Fluorouracil, Leucovorin, Survival",

author = "Axel Grothey",

year = "2006",

month = jan,

doi = "10.1038/ncponc0380",

language = "English (US)",

volume = "3",

pages = "22--23",

journal = "Nature Clinical Practice Oncology",

issn = "1743-4254",